Pharmicell Co., Ltd.
KRX:005690.KS
Overview | Financials
Company Name | Pharmicell Co., Ltd. |
Symbol | 005690.KS |
Currency | KRW |
Price | 5,300 |
Market Cap | 318,021,465,000 |
Dividend Yield | 0% |
52-week-range | 4,300 - 8,870 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Hyun-Soo Kim |
Website | https://www.pharmicell.com |
An error occurred while fetching data.
About Pharmicell Co., Ltd.
Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to enhance the ejection fraction in patients with acute myocardial
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD